Investing in Asia Pacific’s Biotech: Uncovering the Secrets to Investment Successes and Opportunities in the Face of Global Financial Uncertainties

The Asia Pacific (APAC) region has become an increasingly attractive location for investments in recent years. Venture capital investments in South-east Asia hit a record US$20.4 billion in deal value in 2021, which was 85% higher than the previous peak of US$11 billion in 2018, and a 35% increase compared to 2019 and 2020 combined. According to PitchBook data, Singapore attracted the highest VC funding per capita in the world, raking in a total of $4.1 billion in venture capital investment in 2022.
The panel discussion will feature prominent industry leaders who will share their success stories and investment strategies in APAC's biotech industry. Discover how you can leverage the unique strengths and opportunities of this region for investments, including partnerships, biomanufacturing capabilities, and access to the Asian patient population for clinical trials. This would be an excellent opportunity to uncover the secrets to success in APAC's biotech industry and explore the investment potential of this thriving region. This panel discussion is tailored to provide valuable insights for seasoned investors or biotech entrepreneurs alike, on the dynamic and promising biotech landscape in the APAC region amidst global financial uncertainties.